Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that ...

Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that when ...

Merck's stock trades at a low valuation as investors ... The big question is, even if successful, whether many patients will opt for the new form of treatment, which may be more convenient ...

Giant-cell arteritis is a systemic vasculitis with limited treatment options. The efficacy and safety of upadacitinib — a ...

Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Merck To Contact Him Directly To Discuss Their Options ...

Merck already has the world’s biggest selling oral treatment for type 2 diabetes, its DPP-4-based drugs Januvia and Janumet, but it is playing catch-up in the SGLT2 market. The monotherapy and ...

Merck & Co has entered into a worldwide licensing ... and can be a trigger for some forms of cancer and multiple sclerosis. To date, no vaccine against it has been approved, and while several ...

The Bombay High Court on Thursday constituted an expert committee to visit government hospitals in Nanded and Chhatrapati Sambhajinagar districts of Maharashtra and suggest short-term and long-term ...

We’d like to speak with personnel from the Department of Health and Human Services or its component agencies about what’s happening within the federal health bureaucracy. Please message us on Signal ...